Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 17/20 | 0.84 |
| ▸ | CDK2 | P24941 | 3/20 | 0.84 |
| ▸ | CCND1 | P24385 | 3/20 | 0.84 |
| ▸ | GAK | O14976 | 1/20 | 0.84 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.84 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.84 |
| ▸ | FECH | P22830 | 1/20 | 0.84 |
| ▸ | CCND3 | P30281 | 1/20 | 0.84 |
| ▸ | CDK9 | P50750 | 1/20 | 0.84 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.84 |
| ▸ | CDK16 | Q00536 | 1/20 | 0.84 |
| ▸ | MAP3K1 | Q13233 | 1/20 | 0.84 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.84 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.84 |
| ▸ | Q6ZSR9 | Q6ZSR9 | 1/20 | 0.84 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.84 |
| ▸ | SIK2 | Q9H0K1 | 1/20 | 0.84 |
| ▸ | CDK1 | P06493 | 9/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL303528 | 1.00 | CDK4 (0.84) | CDK4CDK2CCND1GAKCCNT1 | |
| SCHEMBL30176533 | 1.00 | CDK4 (0.84) | CDK4CDK2CCND1GAKCCNT1 | |
| SCHEMBL302315 | 1.00 | CDK4 (0.84) | CDK4CDK2CCND1GAKCCNT1 | |
| SCHEMBL30176539 | 1.00 | CDK4 (0.84) | CDK4CDK2CCND1GAKCCNT1 | |
| SCHEMBL302246 | 1.00 | CDK4 (0.84) | CDK4CDK2CCND1GAKCCNT1 | |
| SCHEMBL1993648 | 0.92 | CDK4 (0.85) | CDK4CDK2CCND1GAKCCNT1 | |
| Ribociclib SCHEMBL302310 | 0.91 | CDK4 (1.00) | CDK4CDK2CCND1GAKCCNT1 | |
| SCHEMBL29507480 | 0.91 | CDK4 (0.69) | CDK4CDK2CCND1GAKCCNT1 | |
| Ribociclib SCHEMBL29385337 | 0.91 | CDK4 (1.00) | CDK4CDK2CCND1GAKCCNT1 | |
| Ribociclib SCHEMBL29384231 | 0.91 | CDK4 (1.00) | CDK4CDK2CCND1GAKCCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126244-A1 | COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR TREATMENT | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (CN) | 2023-02-08 | — | — | EP | claimed |
| EP-4126244-A1 | COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR TREATMENT | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (CN) | 2023-02-08 | — | — | EP | disclosed |